Matthew Brams
EVP and Chief Medical Officer at Cingulate Inc. (CING)
Matthew Brams has filed 15 insider reports with the SEC since December 2021, as EVP and Chief Medical Officer at Cingulate Inc. (CING). In the last 12 months Matthew Brams bought $9,808 of stock on the open market. The latest filing, on July 20, 2026, reports grant or award at Cingulate Inc. (CING).
- Filings
- 15
- Companies
- 1
- Bought on market
- $9,808
- Sold on market
- None
Companies where Matthew Brams is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| EVP and Chief Medical Officer | 8,157 | $9,808 | $5.04 | $3.75-26% | Jul 20, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jul 16, 2026CINGSEC Form 4 filed by EVP and Chief Medical Officer Brams MatthewForm 4Grant or award
- Mar 9, 2026CINGEVP and Chief Medical Officer Brams Matthew covered exercise/tax liability with 1,025 shares and was granted 4,526 shares, increasing direct ownership by 75% to 8,157 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Feb 6, 2026+$9,808CINGEVP and Chief Medical Officer Brams Matthew bought $9,808 worth of shares (1,946 units at $5.04), increasing direct ownership by 72% to 4,656 unitsForm 4/AOpen-market purchase
- Jul 7, 2025CINGSEC Form 4 filed by EVP and Chief Medical Officer Brams MatthewForm 4Grant or award
- Feb 18, 2025CINGSEC Form 4 filed by EVP and Chief Medical Officer Brams MatthewForm 4Grant or award
- Jan 17, 2025CINGSEC Form 4 filed by EVP and Chief Medical Officer Brams MatthewForm 4Grant or award
- Dec 31, 2024CINGSEC Form 4 filed by EVP and Chief Medical Officer Brams MatthewForm 4Grant or award
- Sep 30, 2024CINGSEC Form 4 filed by EVP and Chief Medical Officer Brams MatthewForm 4Grant or award
- Jun 28, 2024CINGSEC Form 4 filed by EVP and Chief Medical Officer Brams MatthewForm 4Grant or award
- Jun 11, 2024CINGSEC Form 4 filed by EVP and Chief Medical Officer Brams MatthewForm 4Grant or award
- Mar 29, 2024CINGSEC Form 4 filed by Brams MatthewForm 4Grant or award
- Mar 4, 2024CINGSEC Form 4 filed by Brams MatthewForm 4Grant or award
- Feb 28, 2023CINGSEC Form 4 filed by Brams MatthewForm 4Grant or award
- Feb 25, 2022CINGSEC Form 4 filed by Brams MatthewForm 4Grant or award
- Dec 7, 2021CINGSEC Form 4 filed by Brams MatthewForm 4Grant or award
Compare Matthew Brams with
- Matthew Brams vs Raul R. Silva1 shared
- Matthew Brams vs Shane J. Schaffer1 shared
- Matthew Brams vs Bryan Wade Downey1 shared
- Matthew Brams vs Bryan Jay Lawrence1 shared
- Matthew Brams vs Jennifer L. Callahan1 shared
- Matthew Brams vs Thomas Jeffrey Hargroves1 shared
Other insiders at the same companies
- Raul R. SilvaCING
- Shane J. SchafferCING
- Bryan Wade DowneyCING
- Bryan Jay LawrenceCING
- Jennifer L. CallahanCING
- Thomas Jeffrey HargrovesCING
- Peter J. WerthCING
- Nilay Dahyabhai PatelCING
- Laurie MyersCING
- John A RobertsCING
- Jeffrey S ErvinCING
Questions about Matthew Brams
- What is Matthew Brams's role at Cingulate Inc.?
- Matthew Brams reports to the SEC as EVP and Chief Medical Officer at Cingulate Inc. (CING), according to the latest filing on July 20, 2026.
- How many shares does Matthew Brams own?
- After the latest filing that states it, Matthew Brams directly owned 8,157 shares of Cingulate Inc. (CING). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Matthew Brams bought or sold stock recently?
- The most recent open-market purchase was on February 6, 2026: bought 1,946 shares of Cingulate Inc. (CING) for $9,808 at an average of $5.04.
- How do I get alerts when Matthew Brams files?
- Follow Matthew Brams on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Matthew Brams (SEC CIK 0001884361). Totals count each trade once, skipping amendments whose original is on file, from Dec 9, 2021 on. View on SEC EDGAR